Potential 18f-rgd pet/ct and dce-mri imaging-based biomarkers for postoperative survival prediction among patients with newly diagnosed glioblastoma treated with bevacizumab and chemoradiotherapy

HIGHLIGHTS

• who: Li Li from the University of Erlangen Nuremberg, Germany have published the article: Potential 18F-RGD PET/CT and DCE-MRI Imaging-Based Biomarkers for Postoperative Survival Prediction Among Patients With Newly Diagnosed Glioblastoma Treated With Bevacizumab and Chemoradiotherapy, in the Journal: (JOURNAL) of November/20,/2013
• what: This study shows that 18F-RGD PET/CT and DCE-MRI examination maybe useful for identifying glioblastoma patients likely to benefit from treatment with the combination of bevacizumab and CCRT, with a greater decrease in SUVmean predicting better PFS as well as a smaller decrease in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.